Your Messages Inbox
Most Viewed Abstracts
1. Report Shows Shift in Starting Salaries for Physicians 2. 2008 Exclusive Survey—Earnings: Good news for primary care income 3. Medicare pay-for-reporting effort draws fire from frustrated doctors 4. Debunking Myths in the US Healthcare System 5. Statins and cancer risk
Your Article Summary
See Latest ArticlesVariability in the Prescription of Cholinesterase Inhibitors and Memantine
Dementia and Geriatric Cognitive Disorders, 11/03/09
Villar–Fernández I et al. – Considerable variability in AD treatment has been detected. More consensus is needed to reduce variability in order to improve the quality of the pharmacotherapy for AD and assure equal treatment opportunities for every patient.
Related Articles
Benefit Of Memantine In The Treatment Of Alzheimers Disease Not Proven
ScienceDaily, 10/29/09
Relevance Score: 87%
Memantine versus donepezil in mild to moderate Alzheimer's disease: a randomized trial with magnetic resonance spectroscopy
European Journal of Neurology, 11/03/09
Relevance Score: 85%
Critical appraisal of the long-term impact of memantine in treatment of moderate to severe Alzheimer’s disease
Neuropsychiatric Disease and Treatment, 11/04/09
Relevance Score: 80%
Today in Neuro/Psych pharmacology...keeping you current
Receive free subspecialty "5-minute updates" via email
Propylene Glycol Accumulation in Critically Ill Patients Receiving Continuous Intravenous Lorazepam Infusions
Annals of Pharmacotherapy, 11/25/09
Effect of cilnidipine vs losartan on cerebral blood flow in hypertensive patients with a history of ischemic stroke: a randomized controlled trial
Acta Neurologica Scandinavica, 11/25/09
A 25-week, open-label trial investigating rivastigmine transdermal patches with concomitant memantine in mild-to-moderate Alzheimers disease: a post hoc analysis
Current Medical Research and Opinion, 11/25/09
Sponsor
Article Search
Sponsor